Neoadjuvant Chemoimmunotherapy Complicates Subsequent Surgical Resection and Adjuvant Immunotherapy Is Preferable From the Surgical Standpoint

被引：5
作者：
Figueroa, Paula Ugalde [1 ]
Lacroix, Valerie [2 ]
Van Schil, Paul E. [3 ,4 ,5 ,6 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Thorac Surg, Boston, MA USA
[2] Univ Catholique Louvain UCL, Dept Cardiothorac Surg, Brussels, Belgium
[3] Antwerp Univ Hosp, Dept Thorac & Vasc Surg, Antwerp, Belgium
[4] Antwerp Univ, Antwerp, Belgium
[5] Antwerp Univ Hosp, Dept Thorac & Vasc Surg, Drie Eikenstr 655, B-2650 Edegem, Antwerp, Belgium
[6] Antwerp Univ, Drie Eikenstr 655, B-2650 Edegem, Antwerp, Belgium
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 06期
关键词：
CELL LUNG-CANCER;
D O I：
10.1016/j.jtho.2024.02.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：858 / 861
页数：4
相关论文
共 12 条
[1]   Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations [J].
Baek, Jae ;
Owen, Dwight H. ;
Merritt, Robert E. ;
Shilo, Konstantin ;
Otterson, Gregory A. ;
D'Souza, Desmond M. ;
Carbone, David P. ;
Kneuertz, Peter J. .
CLINICAL LUNG CANCER, 2020, 21 (04) :E265-E269
[2]   Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer [J].
Bott, Matthew J. ;
Yang, Stephen C. ;
Park, Bernard J. ;
Adusumilli, Prasad S. ;
Rusch, Valerie W. ;
Isbell, James M. ;
Downey, Robert J. ;
Brahmer, Julie R. ;
Battafarano, Richard ;
Bush, Errol ;
Chaft, Jamie ;
Forde, Patrick M. ;
Jones, David R. ;
Broderick, Stephen R. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (01) :269-275
[3]   Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial [J].
Felip, Enriqueta ;
Altorki, Nasser ;
Zhou, Caicun ;
Csoszi, Tibor ;
Vynnychenko, Ihor ;
Goloborodko, Oleksandr ;
Luft, Alexander ;
Akopov, Andrey ;
Martinez-Marti, Alex ;
Kenmotsu, Hirotsugu ;
Chen, Yuh-Min ;
Chella, Antonio ;
Sugawara, Shunichi ;
Voong, David ;
Wu, Fan ;
Yi, Jing ;
Deng, Yu ;
McCleland, Mark ;
Bennett, Elizabeth ;
Gitlitz, Barbara ;
Wakelee, Heather .
LANCET, 2021, 398 (10308) :1344-1357
[4]   Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer [J].
Forde, Patrick M. ;
Spicer, Jonathan ;
Lu, Shun ;
Provencio, Mariano ;
Mitsudomi, Tetsuya ;
Awad, Mark M. ;
Felip, Enriqueta ;
Broderick, Stephen R. ;
Brahmer, Julie R. ;
Swanson, Scott J. ;
Kerr, Keith ;
Wang, Changli ;
Ciuleanu, Tudor-Eliade ;
Saylors, Gene B. ;
Tanaka, Fumihiro ;
Ito, Hiroyuki ;
Chen, Ke-Neng ;
Liberman, Moishe ;
Vokes, Everett E. ;
Taube, Janis M. ;
Dorange, Cecile ;
Cai, Junliang ;
Fiore, Joseph ;
Jarkowski, Anthony ;
Balli, David ;
Sausen, Mark ;
Pandya, Dimple ;
Calvet, Christophe Y. ;
Girard, Nicolas .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (21) :1973-1985
[5]   Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials [J].
Fujiwara, Yu ;
Horita, Nobuyuki ;
Adib, Elio ;
Zhou, Susu ;
Nassar, Amin H. ;
Asad, Zain U. L. Abideen ;
Cortellini, Alessio ;
Naqash, Abdul Rafeh .
LANCET ONCOLOGY, 2024, 25 (01) :62-75
[6]   Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer [J].
Heymach, John V. ;
Harpole, David ;
Mitsudomi, Tetsuya ;
Taube, Janis M. ;
Galffy, Gabriella ;
Hochmair, Maximilian ;
Winder, Thomas ;
Zukov, Ruslan ;
Garbaos, Gabriel ;
Gao, Shugeng ;
Kuroda, Hiroaki ;
Ostoros, Gyula ;
Tran, Tho V. ;
You, Jian ;
Lee, Kang-Yun ;
Antonuzzo, Lorenzo ;
Papai-Szekely, Zsolt ;
Akamatsu, Hiroaki ;
Biswas, Bivas ;
Spira, Alexander ;
Crawford, Jeffrey ;
Le, Ha T. ;
Aperghis, Mike ;
Doherty, Gary J. ;
Mann, Helen ;
Fouad, Tamer M. ;
Reck, Martin .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (18) :1672-1684
[7]   Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial [J].
Lu, Shun ;
Zhang, Wei ;
Wu, Lin ;
Wang, Wenxiang ;
Zhang, Peng .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (03) :201-211
[8]   Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial [J].
O'Brien, Mary ;
Paz-Ares, Luis ;
Marreaud, Sandrine ;
Dafni, Urania ;
Oselin, Kersti ;
Havel, Libor ;
Esteban, Emilio ;
Isla, Dolores ;
Martinez-Marti, Alex ;
Faehling, Martin ;
Tsuboi, Masahiro ;
Lee, Jong-Seok ;
Nakagawa, Kazuhiko ;
Yang, Jing ;
Samkari, Ayman ;
Keller, Steven M. ;
Mauer, Murielle ;
Jha, Nitish ;
Stahel, Rolf ;
Besse, Benjamin ;
Peters, Solange .
LANCET ONCOLOGY, 2022, 23 (10) :1274-1286
[9]  
Sepesi Boris, 2022, J Thorac Cardiovasc Surg, V164, P1327, DOI 10.1016/j.jtcvs.2022.01.019
[10]   Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer [J].
Wakelee, Heather ;
Liberman, Moishe ;
Kato, Terufumi ;
Tsuboi, Masahiro ;
Lee, Se-Hoon ;
Gao, Shugeng ;
Chen, Ke-Neng ;
Dooms, Christophe ;
Majem, Margarita ;
Eigendorff, Ekkehard ;
Martinengo, Gaston L. ;
Bylicki, Olivier ;
Rodriguez-Abreu, Delvys ;
Chaft, Jamie E. E. ;
Novello, Silvia ;
Yang, Jing ;
Keller, Steven M. M. ;
Samkari, Ayman ;
Spicer, Jonathan D. D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (06) :491-503
12